Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.48%.

  • Centessa Pharmaceuticals' Return on Capital Employed fell 1500.0% to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.49% for FY2024, which is 200.0% down from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Return on Capital Employed of 0.48% as of Q3 2025, which was down 1500.0% from 0.43% recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.34% for Q3 2024, and its period low was 0.53% during Q1 2023.
  • Its 4-year average for Return on Capital Employed is 0.46%, with a median of 0.49% in 2024.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Return on Capital Employed soared by 1700bps in 2024 and then crashed by -1500bps in 2025.
  • Centessa Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.5% in 2022, then dropped by -4bps to 0.52% in 2023, then increased by 28bps to 0.38% in 2024, then fell by -29bps to 0.48% in 2025.
  • Its last three reported values are 0.48% in Q3 2025, 0.43% for Q2 2025, and 0.37% during Q1 2025.